PlumX Metrics
Embed PlumX Metrics

Update on the Pathogenesis, Virulence, and Treatment of Candida auris

Pathogens and Immunity, ISSN: 2469-2964, Vol: 7, Issue: 2, Page: 46-65
2022
  • 37
    Citations
  • 0
    Usage
  • 92
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Studies from Northeast Ohio Medical University Have Provided New Data on Life Sciences (Update on the Pathogenesis, Virulence, and Treatment of Candida auris)

2022 NOV 08 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Investigators publish new report on life sciences. According to

Article Description

Candida auris is an emerging, multidrug resistant fungal pathogen that causes considerable morbidity and mortality. First identified in Japan in 2009, it has since been reported in more than 40 countries. C. auris can persist for long periods on different environmental surfaces as well as the skin. Clinical isolates are typically resistant to commonly prescribed antifungal drugs. Increasingly recognized as a cause of infections and outbreaks in nosocomial settings, C. auris is difficult to identify using traditional microbiological methods. One of the main reasons for the ongoing spread of C. auris is the multitude of virulence factors it possesses and uses against its human host that enables fungal persistence on the skin surface. Yet, many of the virulence mechanisms are unknown or remain incompletely understood. In this review, we summarize the evolution of virulence of C. auris, offer recommendations for combating this important human pathogen, and suggest directions for further research.

Bibliographic Details

Watkins, Richard R; Gowen, Rachael; Lionakis, Michail S; Ghannoum, Mahmoud

Case Western Reserve University

Medicine; Immunology and Microbiology; Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know